WYX-25021-08441
4 vaccinations
3 coded responses
34 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 254 / WV
- Registered
- 2020-12-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-27
Registered in v-safe
-
2020-12-27
Dose 1 — Pfizer-BioNTech
- 2020-12-27
- 2020-12-28
- 2020-12-29
- 2020-12-30
- 2020-12-31
-
2021-01-01
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-02
- 2021-01-03
- 2021-01-10
-
2021-01-17
Dose 2 — Pfizer-BioNTech
- 2021-01-24
- 2021-01-31
- 2021-02-07
- 2021-02-14
- 2021-02-21
- 2021-02-28
- 2021-04-18
- 2021-07-18
-
2021-09-27
Dose 3 — Pfizer-BioNTech
- 2021-09-30
- 2021-10-01
- 2021-10-02
- 2021-10-03
- 2021-10-04
- 2021-10-11
- 2021-10-18
- 2021-10-25
- 2021-11-01
- 2021-11-08
- 2021-12-27
- 2022-03-28
-
2022-06-02
Dose 4 — Pfizer-BioNTech
- 2022-07-12
-
2022-07-14
Survey response — day 42, dose 4MedDRA: Fatigue, Nasal congestion, Oropharyngeal pain — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Sore throat, stuffy nose, fatigueMedDRA releases: 2024-11 · check-in free text available
-
2022-09-02
Survey response — 3 months, dose 4MedDRA: Cough, Diarrhoea, Nasopharyngitis, Pyrexia, Respiratory tract congestion, Vomiting — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Fever, cold symptoms, cough, congestion, vomiting, diarrheUMedDRA releases: 2024-11 · check-in free text available
-
2022-09-02
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-09-02
-
2022-12-01
Survey response — 6 months, dose 4MedDRA: Thrombosis — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Blood clot in legMedDRA releases: 2024-11 · check-in free text available
-
2022-12-01
Report sent to call center — 6 months, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-12-02
- 2022-12-02
- 2023-06-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-27 | Pfizer-BioNTech | |
| 2 | 2021-01-17 | Pfizer-BioNTech | |
| 3 | 2021-09-27 | Pfizer-BioNTech | No |
| 4 | 2022-06-02 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-09-02 | Unsuccessful | |
| 2022-12-01 | Unsuccessful |
Free text
Release 12 — day 42, dose 4
Symptoms: Sore throat, stuffy nose, fatigue
Release 12 — 3 months, dose 4
Symptoms: Fever, cold symptoms, cough, congestion, vomiting, diarrheU
Release 12 — 6 months, dose 4
Symptoms: Blood clot in leg
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Thrombosis | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release